A palliative care perspective on deprescribing cholinesterase inhibitors in Alzheimer's disease

被引：1
|
作者：
Perri, Giulia-Anna [1 ]
Liao, Pamela [2 ]
机构：
[1] Baycrest Hlth Sci, Dept Family & Community Med, Div Palliat Care, Toronto, ON, Canada
[2] Trillium Hlth Partners Palliat Care, Mississauga, ON, Canada
来源：
CURRENT MEDICAL RESEARCH AND OPINION | 2018年 / 34卷 / 09期
关键词：
HOSPICE ENROLLMENT; DEMENTIA; SYMPTOMS;
D O I：
10.1080/03007995.2018.1490255
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1695 / 1697
页数：3
相关论文
共 50 条
  • [1] Cholinesterase Inhibitors: Cardioprotection in Alzheimer's Disease
    Monacelli, Fiammetta
    Rosa, Gianmarco
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 (04) : 1071 - 1077
  • [2] Adherence to Cholinesterase Inhibitors in Alzheimer's Disease: A Review
    Brady, Roseanna
    Weinman, John
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2013, 35 (5-6) : 351 - 363
  • [3] A clinical overview of cholinesterase inhibitors in Alzheimer's disease
    Farlow, M
    INTERNATIONAL PSYCHOGERIATRICS, 2002, 14 : 93 - 126
  • [4] Pharmacotherapies for Alzheimer's disease: Beyond cholinesterase inhibitors
    Tayeb, Haythum O.
    Yang, Hyun Duk
    Price, Bruce H.
    Tarazi, Frank I.
    PHARMACOLOGY & THERAPEUTICS, 2012, 134 (01) : 8 - 25
  • [5] Pharmacoeconomics of Alzheimer's disease (AD) treatment with cholinesterase inhibitors
    Versijpt, Jan
    ACTA NEUROLOGICA BELGICA, 2012, 112 (02) : 141 - 145
  • [6] Defining optimal treatment with cholinesterase inhibitors in Alzheimer's disease
    Small, Gary
    Bullock, Roger
    ALZHEIMERS & DEMENTIA, 2011, 7 (02) : 177 - 184
  • [7] Adherence, persistence and continuation with cholinesterase inhibitors in Alzheimer's disease
    Le Couteur, David G.
    Robinson, Maxine
    Leverton, Ann
    Creasey, Helen
    Waite, Louise
    Atkins, Kerry
    McLachlan, Andrew J.
    AUSTRALASIAN JOURNAL ON AGEING, 2012, 31 (03) : 164 - 169
  • [8] Cholinesterase inhibitors as Alzheimer's therapeutics
    Sharma, Kamlesh
    MOLECULAR MEDICINE REPORTS, 2019, 20 (02) : 1479 - 1487
  • [9] Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer's disease
    Chalmers, Katy A.
    Wilcock, Gordon K.
    Vinters, Harry V.
    Perry, Elaine K.
    Perry, Robert
    Ballard, Clive G.
    Love, Seth
    JOURNAL OF NEUROLOGY, 2009, 256 (05) : 717 - 720
  • [10] Association of a salivary acetylcholinesterase with Alzheimer's disease and response to cholinesterase inhibitors
    Sayer, R
    Law, E
    Connelly, PJ
    Breen, KC
    CLINICAL BIOCHEMISTRY, 2004, 37 (02) : 98 - 104
12345